Hepatitis C virus entry: possible targets for therapy

Timpe, J M; McKeating, J A
December 2008
Gut;Dec2008, Vol. 57 Issue 12, p1728
Academic Journal
The article discusses Hepatitis C virus (HCV) entry as possible targets for antiviral therapy. It mentions that HCV entry requires specific interactions between HCV envelope glycoproteins and cellular receptors. Although, there are no specific inhibitors of HCV entry, the ability of some individuals to resolve HCV infection suggests that an effective immune response is possible. Further studies are recommended in order to design recombinant antigens that recapitulate such a response.


Related Articles

  • Impaired Hepatitis C Virus (HCV)–Specific Interferon-γ Responses in Individuals With HIV Who Acquire HCV Infection: Correlation With CD4+ T-Cell Counts. Flynn, Jacqueline K.; Dore, Gregory J.; Matthews, Gail; Hellard, Margaret; Yeung, Barbara; Rawlinson, William D.; White, Peter A.; Kaldor, John M.; Lloyd, Andrew R.; Ffrench, Rosemary A. // Journal of Infectious Diseases;Nov2012, Vol. 206 Issue 10, p1568 

    Studies examining the effect of coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) on the HCV-specific immune response in acute HCV infection are limited. This study directly compared acute HCV-specific T-cell responses and cytokine profiles between 20...

  • Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. Puntoriero, Giulia; Meola, Annalisa; Lahm, Armin; Zucchelli, Silvia; Ercole, Bruno Bruni; Tafi, Rosalba; Pezzanera, Monica; Mondelli, Mario U.; Cortese, Riccardo; Tramontano, Anna; Galfre, Giovanni; Nicosia, Alfredo // EMBO Journal;7/1/98, Vol. 17 Issue 13, p3521 

    The hypervariable region 1 (HVR1) of the putative envelope protein E2 of hepatitis C virus (HCV) is the most variable antigenic fragment in the whole viral genome and is mainly responsible for the large inter- and intra-individual heterogeneity of the infecting virus. It contains a principal...

  • Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape Krey, Thomas; Meola, Annalisa; Keck, Zhen-yong; Damier-Piolle, Laurence; Foung, Steven K. H.; Rey, Felix A. // PLoS Pathogens;May2013, Vol. 9 Issue 5, p1 

    The high mutation rate of hepatitis C virus allows it to rapidly evade the humoral immune response. However, certain epitopes in the envelope glycoproteins cannot vary without compromising virus viability. Antibodies targeting these epitopes are resistant to viral escape from neutralization and...

  • Protective Efficacy of Serially Up-Ranked Subdominant CD8+ T Cell Epitopes against Virus Challenges. Im, Eung-Jun; Hong, Jessie P.; Roshorm, Yaowaluck; Bridgeman, Anne; Létourneau, Sven; Liljeström, Peter; Potash, Mary Jane; Volsky, David J.; McMichael, Andrew J.; Hanke, Tomás // PLoS Pathogens;May2011, Vol. 7 Issue 5, Special section p1 

    Immunodominance in T cell responses to complex antigens like viruses is still incompletely understood. Some data indicate that the dominant responses to viruses are not necessarily the most protective, while other data imply that dominant responses are the most important. The issue is of...

  • Advances in the Analysis of Hepatitis C Virus Specific T Cell Responses. Xinjian Zhang; Dou, Jun; Germann, Markus W. // Mini Reviews in Medicinal Chemistry;Feb2011, Vol. 11 Issue 2, p106 

    No abstract available.

  • Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection. Missale, Gabriele; Pilli, Massimo; Zerbini, Alessandro; Penna, Amalia; Ravanetti, Lara; Barili, Valeria; Orlandini, Alessandra; Molinari, Atim; Fasano, Massimo; Santantonio, Teresa; Ferrari, Carlo // Gut;Jul2012, Vol. 61 Issue 7, p1076 

    Background: Hepatitis C virus (HCV) persistence is associated with impaired CD8 functions. Whether functional restoration of CD8 T cells chronically exposed to antigen can be obtained once the antigen is removed remains to be clarified. Objective: To determine whether clearance of HCV by...

  • New Findings in Hepatitis C Immunity. Shirley, Heather // Access;Feb2004, Vol. 18 Issue 2, p8 

    Studies hepatitis C virus (HCV) immunity by researchers from the U.S. Role of HCV on the development of chronic liver diseases; Identification of an essential component that provides immunity against HCV infection; Implications of CD4+ T helper cells and CD8+ killer T cells on the suppression of...

  • HCV-specific T-cell responses during acute Hepatitis C Virus infection in pregnancy. Honegger, Jonathan; Prasad, Mona; Colombo, David; Bowen, David; Walker, Christopher // Retrovirology;2008 Supplement 1, Vol. 5, Special section p1 

    Background While T-cell immune responses are recognized as important determinants of acute hepatitis C virus (HCV) infection outcome in non-pregnant adults, little is known about HCV-specific T-cell immunity during pregnancy or its impact on vertical transmission. Here we describe the temporal...

  • CD8+ T cell responses in acute hepatitis C virus infection. Pil Soo Sung; Racanelli, Vito; Eui-Cheol Shin // Frontiers in Immunology;May2014, Vol. 5, preceding p1 

    Hepatitis C virus (HCV) infects approximately 170 million people worldwide and is a major cause of life-threatening liver diseases such as liver cirrhosis and hepatocellular carcinoma. Acute HCV infection often progresses to chronic persistent infection, although some patients recover...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics